About This Event

Disc Medicine (Nasdaq: IRON), a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders with a portfolio of innovative, first-in-class therapeutic candidates, visits the Nasdaq MarketSite in Times Square. The company completed a reverse merger and began trading on the Nasdaq exchange under the ticker symbol "IRON" on December 30, 2022.

In honor of the occasion, John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc, rings the Opening Bell.